Systematic review of hirudin in acute coronary syndromes and percutaneous coronary intervention

Tools

Perez De Arenaza, Diego, Flather, Marcus D., Shibata, Marcelo C. and Bakhai, Ameet (2001) Systematic review of hirudin in acute coronary syndromes and percutaneous coronary intervention. Current Interventional Cardiology Reports, 3 (2). pp. 156-162. ISSN 1523-3839

Full text not available from this repository. (Request a copy)

Abstract

Thrombin plays a key role in the pathogenesis of acute coronary syndromes because it is a potent platelet agonist and converts fibrinogen to fibrin. Hirudin is a powerful, direct, and specific antithrombin agent that can be used in many therapeutic scenarios in which heparin is routinely used. In this systemic review, we summarize evidence from randomized clinical trials evaluating the benefits and risks of recombinant hirudin for the treatment of acute coronary syndromes and patients undergoing percutaneous coronary intervention.

Item Type:	Article
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School
UEA Research Groups:	Faculty of Medicine and Health Sciences > Research Groups > Norwich Clinical Trials Unit Faculty of Medicine and Health Sciences > Research Groups > Cardiovascular and Metabolic Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023)
Related URLs:	https://pubmed.ncbi.nlm.nih.gov/11322919...
Depositing User:	Pure Connector
Date Deposited:	20 Jan 2014 16:18
Last Modified:	25 Jun 2024 10:30
URI:	https://ueaeprints.uea.ac.uk/id/eprint/46309
DOI:

Actions (login required)

View Item